Venkata Sri Krishna Kona, Deepthi Sri Kanigiri, Lekha Arrolla, Azharuddin Mohammed
{"title":"Overview of ingredients in media formulation for recombinant protein production","authors":"Venkata Sri Krishna Kona, Deepthi Sri Kanigiri, Lekha Arrolla, Azharuddin Mohammed","doi":"10.37022/jiaps.v8i2.467","DOIUrl":null,"url":null,"abstract":"Chemically defined media (CD) have been used in the production of a wide variety of therapies, including growth factors, antibody fragments, and Fc-fusion proteins. However, commercial fermentation with complex ingredients may exhibit variable performance, which can impair product output and quality. In this context, employing CD medium for commercial fermentation becomes a viable option. In spite of the fact that CD medium is often associated with sluggish growth and/or poor productivity, recent research has demonstrated that growth in CD medium may attain a growth profile and protein titer that are comparable to those of its complex medium equivalent. In the process of producing recombinant proteins by fermentation, specified media are particularly useful in cases in which the auxotrophic phenotype of the plasmid being selected for is the driving selection pressure. Fermentation processes are heavily dependent on the development of superior strains through mutagenesis and random screening procedures, as well as the optimization of the environment to which an organism is exposed.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"188 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37022/jiaps.v8i2.467","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Chemically defined media (CD) have been used in the production of a wide variety of therapies, including growth factors, antibody fragments, and Fc-fusion proteins. However, commercial fermentation with complex ingredients may exhibit variable performance, which can impair product output and quality. In this context, employing CD medium for commercial fermentation becomes a viable option. In spite of the fact that CD medium is often associated with sluggish growth and/or poor productivity, recent research has demonstrated that growth in CD medium may attain a growth profile and protein titer that are comparable to those of its complex medium equivalent. In the process of producing recombinant proteins by fermentation, specified media are particularly useful in cases in which the auxotrophic phenotype of the plasmid being selected for is the driving selection pressure. Fermentation processes are heavily dependent on the development of superior strains through mutagenesis and random screening procedures, as well as the optimization of the environment to which an organism is exposed.
化学界定培养基(CD)已被用于生产多种疗法,包括生长因子、抗体片段和 Fc 融合蛋白。然而,使用复杂成分进行商业发酵可能会表现出不同的性能,从而影响产品的产量和质量。在这种情况下,使用 CD 培养基进行商业发酵成为一种可行的选择。尽管 CD 培养基通常与生长缓慢和/或生产率低有关,但最近的研究表明,在 CD 培养基中生长可获得与复合培养基相当的生长曲线和蛋白质滴度。在通过发酵生产重组蛋白的过程中,当质粒的辅助营养表型成为选择压力的驱动力时,特定培养基尤其有用。发酵过程在很大程度上依赖于通过诱变和随机筛选程序培育优良菌株,以及优化生物体所处的环境。